Cargando…
Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
BACKGROUND: Diabetic cardiomyopathy (DCM) is strongly linked to microvascular disease, renin-angiotensin system (RAS) activation, cardiac inflammation and cell apoptosis. Irbesartan is an angiotensin II (Ang II) receptor antagonist in RAS system, which inhibited the conversion of Ang I into Ang II,...
Autores principales: | Xu, Qingmei, Tan, Xin, Xian, Wei, Geng, Jiayi, Li, Haoyu, Tang, Bi, Zhang, Heng, Wang, Hongju, Gao, Qin, Kang, Pinfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434868/ https://www.ncbi.nlm.nih.gov/pubmed/34522112 http://dx.doi.org/10.2147/DMSO.S300388 |
Ejemplares similares
-
Effects of irbesartan on myocardial injury in diabetic rats: The role of NLRP3/ASC/Caspase-1 pathway
por: Rong, Li, et al.
Publicado: (2020) -
Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation
por: Tan, Xin, et al.
Publicado: (2022) -
Metformin mediates cardioprotection against aging‐induced ischemic necroptosis
por: Li, Chen, et al.
Publicado: (2020) -
Necroptosis is required for atrial fibrillation and involved in aerobic exercise‐conferred cardioprotection
por: Fu, Yuping, et al.
Publicado: (2021) -
Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation
por: Nakano, Yasuhiro, et al.
Publicado: (2016)